Disposition of methylglyoxal bis(guanylhydrazone) (MGBG, NSC-32946) in man
- 1 December 1981
- journal article
- case report
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 7 (1) , 31-35
- https://doi.org/10.1007/bf00258210
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- PENETRATION OF METHYLGLYOXAL BIS(GUANYLHYDRAZONE) INTO INTRA-CEREBRAL TUMORS IN HUMANS1981
- High-performance liquid chromatographic analysis of the anticancer agent methylglyoxal bis(guanylhydrazone) (MGBG, NSC-32946) in biological fluidsJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- High-performance liquid chromatographic assay for methylglyoxal bis(guanylhydrazone) (methyl GAG) in plasma and urineJournal of Chromatography A, 1980
- Phase I-II trial of methyl-GAG: a Southwest Oncology Group Pilot Study.1979
- Treatment of acute leukemia with methylglyoxal‐bis‐guanylhydrazone (methyl GAG)Clinical Pharmacology & Therapeutics, 1965
- CELLULAR ACCUMULATION OF METHYLGLYOXAL-BIS-GUANYLHYDRAZONE IN VITRO .I. GENERAL CHARACTERISTICS OF CELLULAR UPTAKE1964
- DISTRIBUTION, EXCRETION, AND METABOLISM OF METHYLGLYOXAL-BIS-GUANTYLHYDRAZONE-C141963
- Methylglyoxal bis (guanylhydrazone): a new agent active against acute myelocytic leukemia.1962
- INITIAL CLINICAL STUDY OF PARENTERAL METHYLGLYOXAL BIS(GUANYLHYDRAZONE) DIACETATE1961
- THE BLOOD SUPPLY OF NEOPLASMS IN THE LIVER1954